Experimental Therapy Crosses Blood-Brain Barrier to Treat Neurological Disease - Cincinnati Children's Blog

Experimental Therapy Crosses Blood-Brain Barrier to Treat Neurological Disease

Researchers in a study led by Cincinnati Children’s have overcome a major challenge to treating brain diseases. The findings will allow the development of drugs that can be tested for other brain diseases like Parkinson’s and Alzheimer’s, according to Dao Pan, PhD, principal investigator on the study and researcher in the Cancer and Blood Diseases Institute at Cincinnati Children’s.

Researchers engineered an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice.

The study was posted online in PNAS Early Edition, a publication of the Proceedings of the National Academy of Sciences.

Read more at ScienceDaily.com.

Subscribe today for more stories, tips and updates.

Cincinnati Children’s News Team

About the Author:

The members of the news team at Cincinnati Children's are responsible for telling the stories of the medical center. Stories of the families we serve, research and clinical care, safe and healthy practices and happenings at the hospital. If it has to do with Cincinnati Children's, Danielle, Nick, Jim, Kate, Rachel, Terry and Shannon will keep you informed.

Write a comment

Comments

No Comments Yet! You can be first to comment on this post!